A team, including researchers from the UC San Francisco Department of Radiology and Biomedical Imaging, investigated a new imaging tool for monitoring response to therapies in patients with glioblastoma (GBM).
The investigators share their conclusions in “Hyperpolarized -[1- 13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma” published in Scientific Reports.
The first authors are Noriaki Minami, MD, PhD, and Dong Hyun Hong, PhD, post-doctoral fellows with UCSF Radiology’s Sabrina Ronen, PhD, who is also the corresponding author. Additional authors from the department include Celine Taglang, PhD, Georgios Batsios, PhD, Anne Marie Gillespie and Pavithra Viswanath, PhD. Nicholas Stevers, Carter Barger, PhD, and Joseph Costello, PhD, from UCSF’s Neurological Surgery Department, were also involved in the study.
The team…
